Premier American Uranium Reports Strong Final Results from its 2025 Drill Program at the Cyclone ISR Project, Wyoming

(TSX-V:PUR),(OTC US:PAUIF),(Other OTC:PAUIF), TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to announce completion of the 2025 exploration drilling program at the Cyclone Rim target area of the Company's wholly-owned Cyclone ISR Uranium Project (“Cyclone” or the “Project“), located […]

Bitfarms Announces Board Chair Transition in Anticipation of U.S. Redomiciliation

(TSX:BITF),(NasdaqGM:BITF), TORONTO, Ontario and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a North American energy and digital infrastructure company, today announced that Edie Hofmeister has been appointed as Chair of the Board of Bitfarms. This appointment supports Bitfarms' previously announced strategy of redomiciling to the United

Westhaven Announces Special Meeting Materials Now Available

(TSX-V:WHN),(TSX-V:WHN.V), VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company“) announces that materials, including a Management Information Circular (the “Circular“) for the upcoming special meeting of shareholders (the “Meeting“), scheduled for February 17, 2026, have been mailed to shareholders of record as of December 30, 2025

Is Data Analytics the Key to Success? YES: Dmitry Shubov Explains Why Businesses Need Data-Driven Insights for Optimal Results

FREMONT, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Many Southeast Asian (SEA) businesses have made it a goal to expand into the U.S. market in 2026. One key factor supporting this is data-driven insights. According to the Gartner 2025 Data and Analytics Report, covered by the National CIO Review, businesses that can strategically use data

Eos Energy Announces Indensity(TM): A Breakthrough in Battery Energy Storage–Join the Launch Event Today at 8:30 a.m. ET

(NASDAQ:EOSE), PITTSBURGH, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), today announced the launch of Eos Indensity(TM)–and invites you to experience it first during an unveiling

Lightbridge to Participate in Upcoming Investor Conferences and Events

(NASDAQ:LTBR), RESTON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that the Company's management team will participate in the following investor conferences and events: 28th Annual Needham Growth Conference on January 14 – New York CityLightbridge President and CEO Seth

Lithium Ionic: 2025 Year in Review – Advancing Toward Construction in Brazil’s Lithium Valley

(TSX-V:LTH),(OTC US:LTHCF),(Other OTC:LTHCF),(Boerse Muenchen – Freiverkehr:H3N),(Boerse Frankfurt – Freiverkehr:H3N), TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to provide a year-end review of its key accomplishments in 2025 and an outlook on priorities for 2026. The past year marked a

Atana Promotes Jeff Carr to Chief Executive Officer

BELLEVUE, Wash., Jan. 14, 2026 (GLOBE NEWSWIRE) — Atana, a leading provider of behavior-based learning and development (L&D) software solutions, today announced the promotion of company president Jeff Carr to the CEO position and his appointment to its board. Carr succeeds company co-founder and former CEO John Hansen, who remains Atana's Executive Chair. Hansen commented,

C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways

(NASDAQ:CCCC), Cemsidomide Phase 2 MOMENTUM Trial On Track to Initiate in Q1 2026; Recommended Phase 2 Dose is 100 ug Cemsidomide Phase 1b Trial in Combination With Elranatamab On Track to Initiate in Q2 2026 Internal Discovery Strategy Progressing Efforts Focused on Inflammation, Neuro-inflammation and Neuro-degenerative Diseases With Novel Targets in Clinically Validated Pathways Cash

The Ultimate Winter Escape is Back: $5 Tuesdays are on at Cineplex

(TSX:CGX), TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — (TSX: CGX) – Starting January 20, Cineplex's $5 Tuesdays return for a limited time, running through February 24, 2026, giving Canadians a reason to turn a winter weeknight into a memorable night out. With a general admission movie ticket and a small bag of popcorn for just

Scroll to Top